Lipo-PGE1, a new lipid-encapsulated preparation of prostaglandin E1: Placebo-and prostaglandin E1-controlled multicenter trials in patients with diabetic neuropathy and leg ulcers-Reference-Cited by-同舟云学术

Lipo-PGE1, a new lipid-encapsulated preparation of prostaglandin E1: Placebo-and prostaglandin E1-controlled multicenter trials in patients with diabetic neuropathy and leg ulcers

Published:1993-11 Issue:5 Volume:46 Page:453-468
ISSN:0090-6980
Container-title:Prostaglandins
language:en
Short-container-title:Prostaglandins

Author:

Toyota T.,Hirata Y.,Ikeda Y.,Matsuoka K.,Sakuma A.,Mizushima Y.

Publisher

Elsevier BV

Subject

Endocrinology,Biochemistry

Reference24 articles.

1. Intravenous prostaglandin E1 in severe peripheral vascular disease;Carlson;Lancet,1976

2. Effects of prostaglandin E1 on microvascular haemodynamics in progressive systemic sclerosis;Martin;BMJ,1982

3. A multi-clinical double blind study with PGE1-(cyclo-dextrin clathrate) in patients with ischemic ulcer of the extremities;Sakaguchi;VASA,1983

4. A multicenter double blind controlled study of lipo-PGE1, PGE1 incorporated in lipid microspheres, in peripheral vascular disease secondary to connective tissue disorders;Mizushima;J Rheumatol,1987

5. Intravenous prostaglandin E1 versus pentoxifylline therapy in chronic arterial occlusive disease - a controlled randomized multicenter study;Trübestein;VASA,1989

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intravenous lipo-prostaglandin E1 administration for patients with acute central retinal artery occlusion;BMJ Open Ophthalmology;2022-05

2. The crosstalk among TLR2, TLR4 and pathogenic pathways; a treasure trove for treatment of diabetic neuropathy;Inflammopharmacology;2022-01-12

3. Prostaglandin E1 protects cardiomyocytes against hypoxia-reperfusion induced injury via the miR-21-5p/FASLG axis;Bioscience Reports;2019-12

4. Sphingosine-1-Phosphate Facilitates Skin Wound Healing by Increasing Angiogenesis and Inflammatory Cell Recruitment with Less Scar Formation;International Journal of Molecular Sciences;2019-07-10

5. Prostaglandin E1 plus methylcobalamin combination therapy versus prostaglandin E1 monotherapy for patients with diabetic peripheral neuropathy;Medicine;2018-11